The company will participate at European Society of Cardiology (ESC) in London August 30th–September 2nd. The Spotlight of ESC Congress 2024 will be ‘Personalising Cardiovascular Care’; a topic devoted to empowering patients through tailored treatments to improve outcomes, reduce risk, and redefine the standard of care.